MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells

Cellular Signalling

Volumn 25, Issue 12, 2013, Pages 2693-2701

  Chen, Zhaolin ^a   Ma, Taotao ^a   Huang, Cheng ^a   Zhang, Lei ^a   Lv, Xiongwen ^a   Xu, Tao ^a   Hu, Tingting ^a   Li, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

FZD7; Hepatocellular carcinoma; MiR 27a; Multiple drug resistance; P glycoprotein; Catenin

Indexed keywords

BETA CATENIN; FLUOROURACIL; FRIZZLED PROTEIN; MESSENGER RNA; MICRORNA; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN FZD7; PROTEIN MIR 27 A; REGULATOR PROTEIN; UNCLASSIFIED DRUG; ABCB1 PROTEIN, HUMAN; ANTINEOPLASTIC ANTIMETABOLITE; FZD7 PROTEIN, HUMAN; MIRN27 MICRORNA, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; DOWN REGULATION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; RNA INTERFERENCE; UPREGULATION; CARCINOMA, HEPATOCELLULAR; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; LIVER NEOPLASMS; METABOLISM; MULTIDRUG RESISTANCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; FRIZZLED RECEPTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MICRORNAS; P-GLYCOPROTEINS; SIGNAL TRANSDUCTION;

EID: 84884575302     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2013.08.032     Document Type: Article

References (50)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. CA Cancer J. Clin. 2011, 61:69-90.
2. Lee J.H., Chung Y.H., Kim J.A., Shim J.H., Lee D., Lee H.C., Shin E.S., Yoon J.H., Kim B.I., Bae S.H., Koh K.C., Park N.H. Cancer 2013, 119:136-142.
3. Toscano-Garibay J.D., Aquino-Jarquin G. DNA Cell Biol. 2012, 31:1358-1364.
4. Leonard G.D., Fojo T., Bates S.E. Oncologist 2003, 8:411-424.
5. Croce C.M., Calin G.A. Cell 2005, 122:6-7.
6. Negrini M., Ferracin M., Sabbioni S., Croce C.M. J. Cell Sci. 2007, 120:1833-1840.
7. Zhu H., Wu H., Liu X., Evans B.R., Medina D.J., Liu C.G., Yang J.M. Biochem. Pharmacol. 2008, 76:582-588.
8. Bao L., Hazari S., Mehra S., Kaushal D., Moroz K., Dash S. Am. J. Pathol. 2012, 180:2490-2503.
9. Kovalchuk O., Filkowski J., Meservy J., Ilnytskyy Y., Tryndyak V.P., Chekhun V.F., Pogribny I.P. Mol. Cancer Ther. 2008, 7:2152-2159.
10. Xu Y., Xia F., Ma L., Shan J., Shen J., Yang Z., Liu J., Cui Y., Bian X., Bie P., Qian C. Cancer Lett. 2011, 310:160-169.
11. Kim S.Y., Kim A.Y., Lee H.W., Son Y.H., Lee G.Y., Lee J.W., Lee Y.S., Kim J.B. Biochem. Biophys. Res. Commun. 2010, 392:323-328.
12. Lin Q., Gao Z., Alarcon R.M., Ye J., Yun Z. FEBS J. 2009, 276:2348-2358.
13. Liu T., Tang H., Lang Y., Liu M., Li X. Cancer Lett. 2009, 273:233-242.
14. Feng J., Iwama A., Satake M., Kohu K. Br. J. Haematol. 2009, 145:412-423.
15. Feng D.D., Zhang H., Zhang P., Zheng Y.S., Zhang X.J., Han B.W., Luo X.Q., Xu L., Zhou H., Qu L.H., Chen Y.Q. J. Cell Mol. Med. 2011, 15:2164-2175.
16. Ma Y., Yu S., Zhao W., Lu Z., Chen J. Cancer Lett. 2010, 298:150-158.
17. van Jaarsveld M.T., Helleman J., Berns E.M., Wiemer E.A. Int. J. Biochem. Cell Biol. 2010, 42:1282-1290.
18. Zhang H., Li M., Han Y., Hong L., Gong T., Sun L., Zheng X. Dig. Dis. Sci. 2010, 55:2545-2551.
19. Li G., Dong S., Qu J., Sun Z., Huang Z., Ye L., Liang H., Ai X., Zhang W., Chen X. Liver Int.: Off. J. Int. Assoc. Study Liver 2010, 30:585-592.
20. Cuestas M.L., Sosnik A., Mathet V.L. Mol. Pharm. 2011, 8:1152-1164.
21. Solazzo M., Fantappie O., Lasagna N., Sassoli C., Nosi D., Mazzanti R. Exp. Cell Res. 2006, 312:4070-4078.
22. Yoo B.K., Chen D., Su Z.Z., Gredler R., Yoo J., Shah K., Fisher P.B., Sarkar D. Cancer Res. 2010, 70:3249-3258.
23. Zhao X., Yang L., Hu J. J. Exp. Clin. Cancer Res.: CR 2011, 30:55.
24. Li Z., Hu S., Wang J., Cai J., Xiao L., Yu L., Wang Z. Gynecol. Oncol. 2010, 119:125-130.
25. Xia H., Ooi L.L., Hui K.M. Hepatology 2013, 58:629-641.
26. Zhu W., Shan X., Wang T., Shu Y., Liu P. J. Int. Cancer 2010, 127:2520-2529.
27. Xu K., Liang X., Shen K., Sun L., Cui D., Zhao Y., Tian J., Ni L., Liu J. Exp. Cell Res. 2012, 318:2168-2177.
28. Wang F., Li T., Zhang B., Li H., Wu Q., Yang L., Nie Y., Wu K., Shi Y., Fan D. Biochem. Biophys. Res. Commun. 2013, 434:688-694.
29. Zhang H., Hao Y., Yang J., Zhou Y., Li J., Yin S., Sun C., Ma M., Huang Y., Xi J.J. Nat. Commun. 2011, 2:554.
30. Chhabra R., Dubey R., Saini N. Molecular Cancer 2010, 9:232.
31. Di Masi A., Viganotti M., Antoccia A., Magrelli A., Salvatore M., Azzalin G., Tosto F., Lorenzetti S., Maranghi F., Mantovani A., Macino G., Tanzarella C., Taruscio D. Cell Mol. Biol. (Noisy-le-grand) 2010, 56:OL1299-OL1317. (Suppl.).
32. Ueno K., Hirata H., Hinoda Y., Dahiya R. J. Int. Cancer 2013, 132:1731-1740.
33. King T.D., Zhang W., Suto M.J., Li Y. Cell. Signal. 2012, 24:846-851.
34. Ueno K., Hazama S., Mitomori S., Nishioka M., Suehiro Y., Hirata H., Oka M., Imai K., Dahiya R., Hinoda Y. Br. J. Cancer 2009, 101:1374-1381.
35. Schmuck R., Warneke V., Behrens H.M., Simon E., Weichert W., Rocken C. Am. J. Pathol. 2011, 178:1792-1804.
36. Kim M., Lee H.C., Tsedensodnom O., Hartley R., Lim Y.S., Yu E., Merle P., Wands J.R. J. Hepatol. 2008, 48:780-791.
37. Yang L., Wu X., Wang Y., Zhang K., Wu J., Yuan Y.C., Deng X., Chen L., Kim C.C., Lau S., Somlo G., Yen Y. Oncogene 2011, 30:4437-4446.
38. Merle P., Kim M., Herrmann M., Gupte A., Lefrancois L., Califano S., Trepo C., Tanaka S., Vitvitski L., de la Monte S., Wands J.R. J. Hepatol. 2005, 43:854-862.
39. Nambotin S.B., Lefrancois L., Sainsily X., Berthillon P., Kim M., Wands J.R., Chevallier M., Jalinot P., Scoazec J.Y., Trepo C., Zoulim F., Merle P. J. Hepatol. 2011, 54:288-299.
40. Sertel S., Eichhorn T., Sieber S., Sauer A., Weiss J., Plinkert P.K., Efferth T. Chem. Biol. Interact. 2010, 185:42-52.
41. Bengochea A., de Souza M.M., Lefrancois L., Le Roux E., Galy O., Chemin I., Kim M., Wands J.R., Trepo C., Hainaut P., Scoazec J.Y., Vitvitski L., Merle P. Br. J. Cancer 2008, 99:143-150.
42. Correa S., Binato R., Du Rocher B., Castelo-Branco M.T., Pizzatti L., Abdelhay E. BMC Cancer 2012, 12:303.
43. Zhang H., Zhang X., Wu X., Li W., Su P., Cheng H., Xiang L., Gao P., Zhou G. Cancer Lett. 2012, 323:106-113.
44. Cai J., Guan H., Fang L., Yang Y., Zhu X., Yuan J., Wu J., Li M. J. Clin. Invest. 2013, 123:566-579.
45. Yamada T., Takaoka A.S., Naishiro Y., Hayashi R., Maruyama K., Maesawa C., Ochiai A., Hirohashi S. Cancer Res. 2000, 60:4761-4766.
46. Li H., Pamukcu R., Thompson W.J. Cancer Biol. Ther. 2002, 1:621-625.
47. Huang M., Wang Y., Sun D., Zhu H., Yin Y., Zhang W., Yang S., Quan L., Bai J., Wang S., Chen Q., Li S., Xu N. BMC Cancer 2006, 6:221.
48. Chen S., Guttridge D.C., You Z., Zhang Z., Fribley A., Mayo M.W., Kitajewski J., Wang C.Y. J. Cell Biol. 2001, 152:87-96.
49. Abad M.J., Bermejo P., Villar A. Gen. Pharmacol. 1995, 26:815-819.
50. Hseu Y.C., Tsou H.T., Kumar K.J., Lin K.Y., Chang H.W., Yang H.L. Evidence-based complementary and alternative medicine: eCAM 2012 2012, 197309.